From: Altered skin microbiome, inflammation, and JAK/STAT signaling in Southeast Asian ichthyosis patients
Clinical manifestations | Patients (# of CI subtype patients with clinical finding) (n = 36) | Frequency (%) |
---|---|---|
Hyperkeratosis (thick skin) | IV(15), HI(8), LI(3), EI(4), TTD(3), ARC(1), SLS(2) | 100 |
Itch/Pruritus | IV(15), HI(8), LI(3), EI(4), TTD(3), ARC(1), SLS(1) | 97.22 |
Skin microbial infection* (n = 18) | IV(9), HI(2), EI(1), TTD(2), SLS(1) | 83.33 |
Erythroderma | IV(10), HI(8), LI(1), EI(4), TTD(2) SLS(1) | 72.22 |
Respiratory comorbidities | IV(10), HI(3), EI(2), TTD(3), SLS(1) | 52.78 |
Sepsis | IV(7), HI (6), LI(2), EI(1), TTD(3) | 52.78 |
Collodion membrane at birth | IV(1), HI(8), LI(3) | 33.33 |
Cardiomyopathy comorbidities | IV(4), HI (2), EI(2), TTD(3) | 30.56 |
Blistering | HI(8), EI(2) | 27.78 |
Loss of heat | HI(3), LI(1), EI(2) | 16.67 |